HomeProductsVinorelbine
Chemical structure of CAS 71486-22-1

Vinorelbine

In Stock•Starting at $52 for 5 mg•Purity ≥ 98%
CAS No.71486-22-1
MDL No.N/A
MFC45H54N4O8
MW778.90
InChI KeyGBABOYUKABKIAF-IELIFDKJSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg98%$52In Stock
10 mg98%$72In Stock
25 mg98%$114In Stock
50 mg98%$165In Stock
100 mg98%$239In Stock
250 mg98%$427In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Vinorelbine is a vinca alkaloid with a norvinblastine skeleton. It functions as an antineoplastic and photosensitizing agent. It is an organic heteropentacyclic and heterotetracyclic compound, as well as a methyl ester, acetate ester, and ring assembly.

CAS No.71486-22-1
Product NameVinorelbine

Biological Targets

TUBB4B·TUBB1·TUBA3C·TUBA4A·TUBB3·

Associated Conditions

embryonal rhabdomyosarcoma·mesothelioma·cancer·malignant colon neoplasm·upper aerodigestive tract neoplasm·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • Vol. 19, Issue 3 • 2001
PMID: 11157011DOI: 10.1200/JCO.2001.19.3.621

Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model.

British journal of cancer • Vol. 84, Issue 2 • 2001
PMID: 11161390PMC: PMC2363703DOI: 10.1054/bjoc.2000.1587

Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine.

Lung cancer (Amsterdam, Netherlands) • Vol. 31, Issue 2-3 • 2001
PMID: 11165406DOI: 10.1016/s0169-5002(00)00176-8

Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.

Lung cancer (Amsterdam, Netherlands) • Vol. 31, Issue 2-3 • 2001
PMID: 11165408DOI: 10.1016/s0169-5002(00)00194-x

Documentation

Similar Products